Table 1.

Participant characteristics

	All participants (N= 84) N (%)*	Cherry extract (N = 41) N (%)*	Diet modification (N=43) N (%)*	p-value
Age, Mean (± SD)	55.8±13.9	58.2±15.5	53.6 ±11.9	0.13
Gender, Male n (%)	61 (72%)	31 (76%)	30 (70%)	0.54
Race, n (%)				0.55
White	57 (68%)	30 (73%)	27 (63%)
Black or African American	21 (25%)	9 (22%)	12 (28%)
Asian/Other1/mixed	6 (7%)	2 (5%)	4 (9%)
Body Mass Index, in Kg/m2, Mean (± SD)	33.3±9.0	32.6±7.9	34.0±10.0	0.49
Sangha Comorbidity Index Score, Mean (± SD)	3.6±3.5	3.3±3.9	4.0±3.0	0.37
Ever Smoked	34 (49%)	15 (37%)	19 (44%)	0.48
Currently smoke	3 (9%)	2 (13%)	1 (5%)	0.41
Alcohol intake, Mean (± SD)
#days past week with drink	1.9±3.0	2.0±2.3	1.7±3.5	0.68
#days past month with drink	6.9±9.5	7.9±9.9	5.9±9.1	0.35
#drinks	1.5±1.8	1.5±1.9	1.4±1.8	0.73
#days with >5 drinks	1.7±4.5	1.8±3.4	1.6±5.4	0.87
Largest #drinks	2.3±3.0	2.4±2.7	2.2±3.2	0.75
Doctor ever prescribed a medication for gout	67 (80%)	31 (76%)	36 (84%)	0.35
Currently taking allopurinol, febuxostat or probenecid2	30 (37%)	13 (33%)	17 (42%)	0.40
#gout flares in the last year, Mean (± SD)	4.0±5.4	4.3±6.0	3.7±4.8	0.62
Baseline HAQ-DI score, Mean (± SD)	0.53±0.7	0.58±0.7	0.49±0.6	0.58
Maximum pain Intensity in last 24 hrs (0–10), Mean (± SD)	2.51±3.0	2.83±3.1	2.21±2.9	0.34
Activity Level				0.87
Sedentary	24 (32%)	13 (33%)	11 (31%)
Low Active	26 (35%)	12 (31%)	14 (39%)
Active	22 (29%)	12 (31%)	10 (28%)
Very Active	3 (4%)	2 (5%)	1 (3%)
Extremely Active	0	0	0
Took survey on 3				0.94
Computer	47 (62%)	22 (62.9%)	25 (61.0%)
Touchscreen	8 (11%)	4 (11.4%)	4 (9.8%)
Smartphone	21 (28%)	9 (25.7%)	12 (29.3%)

^*N (%), unless specified otherwise

¹Other race includes: Native Hawaiian or other pacific islander, American Indian or Alaskan native, Asian, other and mixed

²Missing frequency, n=3

³Missing frequency, n=8